PH26103A - Solvates of B-lactam antibiotic - Google Patents

Solvates of B-lactam antibiotic Download PDF

Info

Publication number: PH26103A
Authority: PH; Philippines
Prior art keywords: dmf; solution; mono; mixture; solvate
Prior art date: 1988-11-14

Application number

PH39508A

Other languages

English (en)

Inventor

Thomas Michael Echrich

Richard Charles Hoying

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-14

Filing date

1989-11-10

Publication date

1992-02-06

1989-11-10 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1992-02-06 Publication of PH26103A publication Critical patent/PH26103A/en

Links

239000012453 solvate Substances 0.000 title claims description 42
230000003115 biocidal effect Effects 0.000 title description 5
150000001875 compounds Chemical class 0.000 claims description 21
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
238000000634 powder X-ray diffraction Methods 0.000 claims description 10
239000010949 copper Substances 0.000 claims description 5
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
229910052802 copper Inorganic materials 0.000 claims description 4
230000005855 radiation Effects 0.000 claims description 4
YXLFCICVCJCCKR-UHFFFAOYSA-N n,n-dimethylformamide;dihydrate Chemical compound O.O.CN(C)C=O YXLFCICVCJCCKR-UHFFFAOYSA-N 0.000 claims description 3
JAPHQRWPEGVNBT-UTUOFQBUSA-N loracarbef Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C([O-])=O)=O)[NH3+])=CC=CC=C1 JAPHQRWPEGVNBT-UTUOFQBUSA-N 0.000 abstract description 32
150000004683 dihydrates Chemical class 0.000 abstract description 13
150000004682 monohydrates Chemical group 0.000 abstract description 9
239000000543 intermediate Substances 0.000 abstract description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 48
239000000203 mixture Substances 0.000 description 30
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 25
238000007792 addition Methods 0.000 description 18
238000000034 method Methods 0.000 description 16
229940086542 triethylamine Drugs 0.000 description 16
239000000725 suspension Substances 0.000 description 15
239000002253 acid Substances 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
239000007787 solid Substances 0.000 description 13
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
229960000443 hydrochloric acid Drugs 0.000 description 11
235000011167 hydrochloric acid Nutrition 0.000 description 11
-1 2,2,2-tribromoethyl Chemical group 0.000 description 10
238000001914 filtration Methods 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 9
238000005917 acylation reaction Methods 0.000 description 8
239000011541 reaction mixture Substances 0.000 description 8
GPYKKBAAPVOCIW-HSASPSRMSA-N (6r,7s)-7-[[(2r)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate Chemical compound O.C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 GPYKKBAAPVOCIW-HSASPSRMSA-N 0.000 description 7
230000010933 acylation Effects 0.000 description 7
239000007858 starting material Substances 0.000 description 7
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
125000002252 acyl group Chemical group 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
150000002148 esters Chemical class 0.000 description 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
125000006239 protecting group Chemical group 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
MASDFXZJIDNRTR-UHFFFAOYSA-N 1,3-bis(trimethylsilyl)urea Chemical compound C[Si](C)(C)NC(=O)N[Si](C)(C)C MASDFXZJIDNRTR-UHFFFAOYSA-N 0.000 description 4
GKQLYSROISKDLL-UHFFFAOYSA-N EEDQ Chemical compound C1=CC=C2N(C(=O)OCC)C(OCC)C=CC2=C1 GKQLYSROISKDLL-UHFFFAOYSA-N 0.000 description 4
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
150000001732 carboxylic acid derivatives Chemical group 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
238000003828 vacuum filtration Methods 0.000 description 4
238000005160 1H NMR spectroscopy Methods 0.000 description 3
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 3
239000013078 crystal Substances 0.000 description 3
238000002425 crystallisation Methods 0.000 description 3
230000008025 crystallization Effects 0.000 description 3
230000001747 exhibiting effect Effects 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
239000000047 product Substances 0.000 description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
238000003756 stirring Methods 0.000 description 3
238000007864 suspending Methods 0.000 description 3
ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
238000005481 NMR spectroscopy Methods 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
238000007605 air drying Methods 0.000 description 2
150000008064 anhydrides Chemical class 0.000 description 2
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
125000004185 ester group Chemical group 0.000 description 2
239000003365 glass fiber Substances 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
229940098779 methanesulfonic acid Drugs 0.000 description 2
XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
238000010899 nucleation Methods 0.000 description 2
125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical group OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 2
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
239000002002 slurry Substances 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229940083608 sodium hydroxide Drugs 0.000 description 2
235000011121 sodium hydroxide Nutrition 0.000 description 2
238000001291 vacuum drying Methods 0.000 description 2
NFGMWAKGHQALBE-KVGGNSOTSA-N (4-nitrophenyl)methyl (4r,5s,6s)-6-[(1r)-1-hydroxyethyl]-4-methyl-3-[(3s,5s)-1-[(4-nitrophenyl)methoxycarbonyl]-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound N1([C@H](CNS(N)(=O)=O)C[C@@H](C1)SC=1[C@H](C)[C@@H]2[C@H](C(N2C=1C(=O)OCC=1C=CC(=CC=1)[N+]([O-])=O)=O)[C@H](O)C)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 NFGMWAKGHQALBE-KVGGNSOTSA-N 0.000 description 1
CFGDUGSIBUXRMR-UHFFFAOYSA-N 1,2-dihydropyrrol-2-ide Chemical class C=1C=[C-]NC=1 CFGDUGSIBUXRMR-UHFFFAOYSA-N 0.000 description 1
BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
HSQFVBWFPBKHEB-UHFFFAOYSA-N 2,3,4-trichlorophenol Chemical group OC1=CC=C(Cl)C(Cl)=C1Cl HSQFVBWFPBKHEB-UHFFFAOYSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical group OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
WDRFYIPWHMGQPN-UHFFFAOYSA-N 2-chloroisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(Cl)C(=O)C2=C1 WDRFYIPWHMGQPN-UHFFFAOYSA-N 0.000 description 1
ZKUIZEYJZXEIJW-UHFFFAOYSA-N 2-chloropyridine;iodomethane Chemical compound IC.ClC1=CC=CC=N1 ZKUIZEYJZXEIJW-UHFFFAOYSA-N 0.000 description 1
WABGXXAOZFQROS-UHFFFAOYSA-N 2-fluoropyridine iodomethane Chemical compound IC.FC1=CC=CC=N1 WABGXXAOZFQROS-UHFFFAOYSA-N 0.000 description 1
ZANNVEVFCNOBBB-UHFFFAOYSA-N 4-(iminomethylideneamino)-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(N=C=N)C=C1 ZANNVEVFCNOBBB-UHFFFAOYSA-N 0.000 description 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical group OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 description 1
NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 description 1
HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 1
NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
238000004566 IR spectroscopy Methods 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
238000003109 Karl Fischer titration Methods 0.000 description 1
239000013543 active substance Substances 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
239000012296 anti-solvent Substances 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
239000003782 beta lactam antibiotic agent Substances 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
239000006229 carbon black Substances 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
125000006182 dimethyl benzyl group Chemical group 0.000 description 1
XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
150000002081 enamines Chemical class 0.000 description 1
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
229960002449 glycine Drugs 0.000 description 1
125000001188 haloalkyl group Chemical group 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
UHAAFJWANJYDIS-UHFFFAOYSA-N n,n'-diethylmethanediimine Chemical compound CCN=C=NCC UHAAFJWANJYDIS-UHFFFAOYSA-N 0.000 description 1
MALMHIVBMJBNGS-UHFFFAOYSA-N n,n'-dipropylmethanediimine Chemical compound CCCN=C=NCCC MALMHIVBMJBNGS-UHFFFAOYSA-N 0.000 description 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
239000003495 polar organic solvent Substances 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000008213 purified water Substances 0.000 description 1
239000002516 radical scavenger Substances 0.000 description 1
125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
125000004665 trialkylsilyl group Chemical group 0.000 description 1
125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000002132 β-lactam antibiotic Substances 0.000 description 1
229940124586 β-lactam antibiotics Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Compounds Of Unknown Constitution (AREA)

PH39508A 1988-11-14 1989-11-10 Solvates of B-lactam antibiotic PH26103A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27154588A	1988-11-14	1988-11-14

Publications (1)

Publication Number	Publication Date
PH26103A true PH26103A (en)	1992-02-06

Family

ID=23036044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH39508A PH26103A (en)	1988-11-14	1989-11-10	Solvates of B-lactam antibiotic

Country Status (20)

Country	Link
EP (1)	EP0369687B1 (de)
JP (1)	JP2842640B2 (de)
KR (1)	KR0145556B1 (de)
CN (1)	CN1025333C (de)
AT (1)	ATE136306T1 (de)
AU (1)	AU614440B2 (de)
CA (1)	CA2002597C (de)
DE (1)	DE68926148T2 (de)
DK (1)	DK170701B1 (de)
ES (1)	ES2085281T3 (de)
GR (1)	GR3019677T3 (de)
HU (1)	HU203756B (de)
IE (1)	IE74167B1 (de)
IL (1)	IL92270A (de)
MX (1)	MX18317A (de)
NZ (1)	NZ231369A (de)
PH (1)	PH26103A (de)
PT (1)	PT92270B (de)
RU (3)	RU2002749C1 (de)
ZA (1)	ZA898612B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5097943A (en) *	1986-02-05	1992-03-24	Nisshinbo Industries, Inc.	Bobbin transfer appartaus in spinning processes
US5074401A (en) *	1988-06-16	1991-12-24	Kabushiki Kaisha Toyoda Jidoshokki Seisakusho	Bobbin-carrying apparatus of a combined fine spinning machine and winder
CA2002596A1 (en) *	1988-11-14	1990-05-14	Thomas M. Eckrich	Hydrates of b-lactam antibiotic
CA2034592C (en) *	1990-01-26	2001-06-05	Ralph R. Pfeiffer	Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5352782A (en) *	1993-06-04	1994-10-04	Eli Lilly And Company	Process for preparing crystalline β-lactam monohydrate
US5550231A (en) *	1993-06-15	1996-08-27	Eli Lilly And Company	Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5580977A (en) *	1995-03-01	1996-12-03	Eli Lilly And Company	Process for preparing loracarbef monohydrate
WO1999024441A1 (en) *	1997-11-10	1999-05-20	Dsm N.V.	Crystallization of beta-lactam compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO155548C (no) *	1979-02-10	1987-04-15	Kyowa Hakko Kogyo Kk	Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
CA1334970C (en) *	1987-10-06	1995-03-28	Carol Elaine Pasini	Crystalline .beta.-lactam hydrate
IL89150A0 (en) *	1988-02-05	1989-09-10	Lilly Co Eli	Crystalline beta-lactam solvate
CA2002596A1 (en) *	1988-11-14	1990-05-14	Thomas M. Eckrich	Hydrates of b-lactam antibiotic

1989
- 1989-11-09 CA CA002002597A patent/CA2002597C/en not_active Expired - Fee Related
- 1989-11-10 IL IL9227089A patent/IL92270A/en not_active IP Right Cessation
- 1989-11-10 DE DE68926148T patent/DE68926148T2/de not_active Expired - Fee Related
- 1989-11-10 EP EP89311637A patent/EP0369687B1/de not_active Expired - Lifetime
- 1989-11-10 ZA ZA898612A patent/ZA898612B/xx unknown
- 1989-11-10 ES ES89311637T patent/ES2085281T3/es not_active Expired - Lifetime
- 1989-11-10 DK DK563689A patent/DK170701B1/da not_active IP Right Cessation
- 1989-11-10 MX MX1831789A patent/MX18317A/es unknown
- 1989-11-10 PT PT92270A patent/PT92270B/pt active IP Right Grant
- 1989-11-10 PH PH39508A patent/PH26103A/en unknown
- 1989-11-10 AT AT89311637T patent/ATE136306T1/de not_active IP Right Cessation
- 1989-11-10 AU AU44572/89A patent/AU614440B2/en not_active Ceased
- 1989-11-11 KR KR1019890016364A patent/KR0145556B1/ko not_active Expired - Fee Related
- 1989-11-13 HU HU895881A patent/HU203756B/hu not_active IP Right Cessation
- 1989-11-13 RU SU894742500A patent/RU2002749C1/ru not_active IP Right Cessation
- 1989-11-13 NZ NZ231369A patent/NZ231369A/en unknown
- 1989-11-13 IE IE364189A patent/IE74167B1/en not_active IP Right Cessation
- 1989-11-13 JP JP1294752A patent/JP2842640B2/ja not_active Expired - Fee Related
- 1989-11-13 CN CN89108711A patent/CN1025333C/zh not_active Expired - Fee Related
1990
- 1990-12-20 RU SU904831903A patent/RU1833387C/ru active
- 1990-12-20 RU SU904831933A patent/RU2028298C1/ru not_active IP Right Cessation
1996
- 1996-04-19 GR GR960401054T patent/GR3019677T3/el unknown

Also Published As

Publication number	Publication date
PT92270B (pt)	1995-08-09
EP0369687B1 (de)	1996-04-03
GR3019677T3 (en)	1996-07-31
IE74167B1 (en)	1997-07-02
NZ231369A (en)	1991-03-26
KR0145556B1 (ko)	1998-08-17
RU1833387C (ru)	1993-08-07
DK563689A (da)	1990-05-15
KR900007839A (ko)	1990-06-02
AU4457289A (en)	1990-05-31
CN1025333C (zh)	1994-07-06
ES2085281T3 (es)	1996-06-01
CN1042711A (zh)	1990-06-06
EP0369687A1 (de)	1990-05-23
IE893641L (en)	1990-05-14
CA2002597C (en)	1999-03-23
DE68926148T2 (de)	1996-09-19
CA2002597A1 (en)	1990-05-14
DK563689D0 (da)	1989-11-10
JP2842640B2 (ja)	1999-01-06
DK170701B1 (da)	1995-12-11
PT92270A (pt)	1990-05-31
DE68926148D1 (de)	1996-05-09
MX18317A (es)	1993-11-01
IL92270A (en)	1994-10-21
AU614440B2 (en)	1991-08-29
HU203756B (en)	1991-09-30
IL92270A0 (en)	1990-07-26
ATE136306T1 (de)	1996-04-15
HUT52507A (en)	1990-07-28
JPH02180882A (ja)	1990-07-13
RU2002749C1 (ru)	1993-11-15
RU2028298C1 (ru)	1995-02-09
ZA898612B (en)	1991-07-31

Publication	Publication Date	Title
US5091525A (en)	1992-02-25	Monohydrate and DMF solvates of a new carbacephem antibiotic
NL8003003A (nl)	1980-11-27	Tussenprodukten te gebruiken bij de bereiding van cefalosporine antibiotica.
CA2002597C (en)	1999-03-23	Solvates of b-lactam antibiotic
US4977257A (en)	1990-12-11	DMF solvates of a β-lactam antibiotic
CA1140112A (en)	1983-01-25	Broad spectrum cephalosporin antibiotics
US4148817A (en)	1979-04-10	Process and intermediates for preparing cephalosporin antibiotics
US5639877A (en)	1997-06-17	Intermediates in the synthesis of cephalosporins
FI73968C (fi)	1987-12-10	Foerfarande foer framstaellning av fenylglycylkloridhydroklorider.
IE56485B1 (en)	1991-08-14	Improvements in or relating to novel cephalosporin intermediates
AU615026B2 (en)	1991-09-19	Crystalline beta-lactam solvate
CA1339213C (en)	1997-08-05	Substantially anhydrous crystalline cefadroxil and method for producing it
US5672700A (en)	1997-09-30	Loracarbef isopropanolate
HU180687B (en)	1983-04-29	Process for preparing 7-acyl-amido-ceph-3-eme-4-carboxylic acid derivatives
US5578720A (en)	1996-11-26	Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US4098796A (en)	1978-07-04	P-trimethylsilyloxyphenyl glycyloxyphthalimide
US4178294A (en)	1979-12-11	p-Trimethylsilyloxyphenyl glycyloxy succinimide
US4091214A (en)	1978-05-23	De-esterification process for cephalosporins
US4005074A (en)	1977-01-25	Process for cleaving an imido side chain from penicillins and cephalosporins
US4223134A (en)	1980-09-16	Process for preparing cephalosporin antibiotics
GB2193213A (en)	1988-02-03	6-trifluoromethyl-1H-benzotriazol-1-yl diphenylphosphate and its use in preparing cephalosporin derivatives
KR830002896B1 (ko)	1983-12-30	세팔로스포린 유도체의 제조방법
US20060205938A1 (en)	2006-09-14	Monohydrate solvates of loracarbef
JPS59144787A (ja)	1984-08-18	２−オキソアゼチジン誘導体
JPS62228084A (ja)	1987-10-06	セフアロスポリン誘導体
JPS60233090A (ja)	1985-11-19	セフエム誘導体の製造方法